|
 |
PeriostatThis page contains recent news articles, when available, and an overview of Periostat but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Periostat (when available) Doxycycline, a long-acting tetracycline derived from oxytetracycline, is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with COPD, and adult periodontitis. For the treatment of the following infections:Rocky mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae, Chancroid caused by Haemophilus ducreyi, Uncomplicated gonorrhea caused by Neisseria gonorrhoeae, Respiratory tract infections caused by Mycoplasma pneumoniae or Streptococcus pneumoniae. Lymphogranuloma ve Mechanism Of Action: Doxycycline, like minocycline, is lipophilic and can pass through the lipid bilayer of bacteria. Doxycycline reversibly binds to the 30 S ribosomal subunits and possibly the 50S ribosomal subunit(s), blocking the binding of aminoacyl tRNA to the mRNA and inhibiting bacterial protein synthesis. News Articles on Doxycycline æ–°ç”¨é€”æ‹‰åŠ¨å››çŽ¯ç´ èµ·æ»å›žç”Ÿ - Dec 27, 2009 ...的抗骨质ç–?æ?¾è?¯ï¼Œè€Œä¸€ç§?æ–°çš„å››çŽ¯ç´ è¡?生è?¯ç‰©Periostat能有效治疗慢性牙龈炎，å?¦å¤–，新å?‘çŽ°çš„å››çŽ¯ç´ è¡?生物还å?¯ä»¥ç”¨äºŽæ²»ç–—牙龈炎以å?Šæ²»ç–—导致艾滋病人æ»äº¡çš„主è¦?ç—…å› â€• ... 新浪网 Newtown, Pa.-based drug maker CollaGenex to slash workforce.( … - May 17, 2005 In anticipation of lower-cost generic competition, CollaGenex said it expects "a significant and immediate reduction in number of Periostat prescriptions ... Free with registration - Philadelphia Inquirer - AccessMyLibrary.com Periostat (doxycycline 20mg) - Jan 28, 2006 Please send trade news information and illustrations to Arveen Bajaj at the BDJ, Nature Publishing Group, The Macmillan Building, 4–6 Crinan Street, ... Nature.com Generic Periostat drug gets OK - May 13, 2005 Ivax Corp. of Miami received marketing approval from the Food and Drug Administration for a generic version of the gum disease treatment Periostat in the ... Philadelphia Business Journal Galderma Pharma set to take over CollaGenex - Apr 7, 2008 It shifted its focus to dermatology after discovering its lead gum disease product, Periostat, also helped treat skin problems. ... Bizjournals.com CollaGenex's move to prevent launch of generic Periostat denied - Jun 16, 2005 CollaGenex Pharmaceuticals Inc. on Thursday said that its motion seeking a temporary restraining order and a preliminary injunction in US District Court for ... Philadelphia Business Journal Q1 2005 CollaGenex Pharmaceuticals, Inc. Earnings Conference Call - … - May 5, 2005 So while the level of Periostat prescriptions was about the same in the first quarter of this ... After a third-party generic form of Periostat is launched, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com CollaGenex wins FDA approval for Oracea. - May 30, 2006 Largely due to the erosion of Periostat sales, CollaGenex reported a 2005 net loss of $18.8 million, compared to a net income of $6.5 million for the year ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Loislaw Federal District Court Opinions - COLLAGENEX … - Jan 19, 2005 ...fn2] Periostat was the first — and remains the only — systemic drug that ... Periostat helps keep the tooth attached to the gum, over and above the normal ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw CollaGenex Pharmaceuticals Reports Financial Results for the Second … - Aug 1, 2005 The Company's financial results during the second quarter of 2005 reflect the launch, in May 2005, of generic competition against Periostat(R), ... businesswire.com CollaGenex Pharmaceuticals “buy,â€? target price raised - Mar 14, 2008 According to Roth Capital, the company's Periostat product would drive revenues in 2005. The EPS estimates for 2004 and 2005 are $0.42 and $0.95, ... newratings.com CollaGenex Pharmaceuticals Reports Financial Results for the Fourth … - Mar 10, 2005 Total Periostat tablets dispensed during the fourth quarter of 2004, including Mutual's branded version of Periostat, were 2% higher than the third quarter ... $4.95 - Business Wire - ECNext COURIER TIMES - Aug 2, 2006 Stewart said revenues fell after CollaGenex's signature dental drug, Periostat, lost its patent protection and became available as a generic. ... $3.50 - Bucks County Courier Times - NewsBank 2 makers back off selling generic Periostat, for now - Jan 25, 2005 CollaGenex Pharmaceuticals Inc. announced two generic drug companies, Ivax Pharmaceuticals Inc. and CorePharma LLC, agreed to refrain from selling generic ... Philadelphia Business Journal Generic versions of Periostat still available.(PIPELINE PREVIEWS) - Sep 1, 2005 CollaGenex Pharmaceuticals, Inc., announced that the United States District Court for the Eastern District of New York has denied its motion seeking a ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com … Prevents Sales of Generic Versions of Periostat Pending Hearing on... - Jan 24, 2005 Periostat is the brand name of CollaGenex's proprietary 20mg tablets of ... "We have a valid patent covering Periostat and we will continue to pursue every ... $4.95 - Business Wire - ECNext … ; Companies agree to temporarily halt sale of generic versions of... - Feb 21, 2005 Periostat is the brand name of CollaGenex's proprietary 20 mg tablets of doxycycline ... "We have a valid patent covering Periostat and we will continue to ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Q2 2005 CollaGenex Pharmaceuticals, Inc. Earnings Conference Call - … - Aug 2, 2005 Our financial performance during the quarter reflected the launch of generic competition against Periostat in May of this year. Following the denial of our ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com … ; Companies agree to temporarily halt sale of generic versions of... - Feb 25, 2005 Periostat is the brand name of CollaGenex's proprietary 20 mg tablets of doxycycline ... "We have a valid patent covering Periostat and we will continue to ... Pay-Per-View - Drug Week - Factiva, from Dow Jones First-Time Generic Approvals: Periostat, TriCor, Foscavir - Jun 21, 2005 June 21, 2005 — The US Food and Drug Administration (FDA) has approved first-time generic formulations of doxycycline hyclate 20-mg tablets USP for ... Medscape CollaGenex acquired for $420 million - Shares leapt 27.6%. A Texas... - Feb 27, 2008 CollaGenex, founded in 1992, still sells Periostat, with $2.5 million in annual sales, down from $46 million in 2004, before the arrival of lower-cost ... $2.95 - Philadelphia Inquirer - NewsBank CollaGenex moving to protect patent - Jan 20, 2005 Periostat is the registered trademark of CollaGenex's proprietary 20-milligram tablets of doxycycline hyclate, which the FDA has approved as an adjunct ... South Florida Business Journal Treatment of chronic periodontitis - Aug 26, 2006 Periostat, distributed by Alliance Pharmaceuticals, is one of the latest ... The duration of treatment with Periostat, a prescription only medicine, ... Nature.com … Notifies CollaGenex That It Will Confirm Claims of Reexamined... - Mar 7, 2005 Periostat is the first and only pharmaceutical to treat periodontal disease by ... CollaGenex is further evaluating Periostat and other IMPACS(R) compounds, ... $4.95 - Business Wire - ECNext CollaGenex Pharmaceuticals Reports Highly Significant Outcomes of … - Jun 6, 2005 CollaGenex currently sells Periostat(R) as the first and only pharmaceutical ... Periostat(R) is a registered trademark and Restoraderm(TM), IMPACS(TM) and ... RedOrbit … ; US patent office says it will confirm claims of reexamined Periost... - Apr 4, 2005 In the reexamination process, CollaGenex successfully demonstrated to the patent office that enhancement of bone protein synthesis using Periostat, ... Pay-Per-View - Managed Care Weekly Digest - Factiva, from Dow Jones … motion to prevent generic Periostat.(CollaGenex Pharmaceuticals... - Jul 11, 2005 CollaGenex Pharmaceuticals of the USA says that its motion seeking a temporary restraining order and a preliminary injunction in the US District Court for ... $4.95 - Pharma Marketletter - ECNext Which antibiotic for rosacea? Minocycline and doxycycline both have … - Feb 15, 2007 In 1998, the FDA approved Periostat (doxycyline hyclate, ... (Some eye care practitioners prescribe Periostat off-label for ocular rosacea. ... Free with registration - Review of Optometry - AccessMyLibrary.com Magistrate Recommends Denial of CollaGenex Pharmaceuticals Motion … - Mar 17, 2005 Periostat is the registered trademark of CollaGenex's proprietary 20 mg tablets of ... Periostat is the first and only pharmaceutical to treat periodontal ... $4.95 - Business Wire - ECNext CollaGenex Pharmaceuticals Reports Financial Results for the Fourth … - Feb 28, 2006 ...in the fourth quarter of 2004, reflecting significantly reduced sales of Periostat(R) following the introduction of generic competition in May 2005. ... $4.95 - Business Wire - ECNext Federal Register 2005 - 70 FR 25832 CollaGenex Pharmaceuticals, Inc.;... - May 16, 2005 FDA has determined that PERIOSTAT (doxycycline hyclate) 20-mg capsules were not withdrawn from sale for reasons of safety or effectiveness. ... Pay-Per-View - Federal Register 2005 - Loislaw Baird Capital Partners acquires Med Educ Tech Inc from L-3 … - Oct 9, 2008 Condition Treated Trial Phase Source Partner Periostat Periodontitis M Dentaplex Dietary… COLLAGENEX PHARMACEUTICALS INC-COMPANY INSIGHT · COLLAGENEX ... Pay-Per-View - deals - Alacra Store Myasthenia Gravis: a review for dental hygienists. | Article from... - Jan 1, 2007 Periostat is a new formulation of a 20 mg, subantimicrobial dose of doxycycline hyclate that is used in the treatment of periodontal disease. ... Pay-Per-View - Journal of Dental Hygiene - HighBeam Research Bucks County Courier Times : Coming<br>back<br>stronger - Jan 29, 2006 Patients taking Periostat, a chemically modified tetracycline, had told their ... Periostat, on the other hand, brought in about $50 million in sales. ... $3.50 - Bucks County Courier Times - NewsBank Business & Finance; CollaGenex Pharmaceuticals reports financial … - Aug 29, 2006 Total net revenues: Net revenues from Periostat, Pandel, the Atrix products, contract revenues from the Primus products and grant revenue from the ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Article: vital: Brush up on oral health.. NOW YOU HAVE A REASON TO … - Oct 1, 2007 The government ... concept" in treating gum disease, said Dr. Sebastian ... bones that hold teeth in place. Periostat ... perhaps even halt, gum disease. ... Pay-Per-View - Daily Record - HighBeam Research CollaGenex Pharmaceuticals Reports Positive Outcome of Phase 2 … - Apr 15, 2005 Periostat is the first and only pharmaceutical to treat periodontal disease by ... CollaGenex is further evaluating Periostat and other IMPACS compounds, ... RedOrbit Gamma Holding NV acquires uni-chains A/S (pending) - Deal Snapshot - ... - Dec 3, 2007 ...provides Mutual a license to sell a branded version of CollaGenex's Periostat tablet s, which will be provided as private label by Collagenex under…for ... Pay-Per-View - deals - Alacra Store CollaGenex Pharmaceuticals to Hold First Quarter 2005 Earnings … - Apr 28, 2005 Periostat is the first and only pharmaceutical to treat periodontal disease by ... CollaGenex is further evaluating Periostat and other IMPACS compounds, ... $4.95 - Business Wire - ECNext Shares Up on FDA's OK of CollaGenex Skin Drug - Jun 2, 2006 Oracea is a formulation of doxycycline, the same active ingredient in CollaGenex's gum-disease treatment Periostat. The company began developing Oracea ... RedOrbit WHY GUMS MATTER, Besides tooth loss, periodontal problems have … - Feb 27, 2007 Periostat, a medication developed at Stony Brook's Dental School, has also proven useful in inhibiting enzymes that break down the collagen and cause bone ... Pay-Per-View - Newsday - ProQuest Archiver CollaGenex Pharmaceuticals Reports Financial Results for the Second … - Aug 2, 2006 ...to $6.9 million in the second quarter of 2005, reflecting reduced sales of Periostat(R) following the introduction of generic competition in May 2005. ... Genetic Engineering News - Genetic Engineering News (press release) CollaGenex Pharmaceuticals to Hold Fourth Quarter and Year End 2004 … - Mar 1, 2005 Periostat is the first and only pharmaceutical to treat periodontal disease by ... CollaGenex is further evaluating Periostat and other IMPACS(R) compounds, ... $4.95 - Business Wire - ECNext Patents; CollaGenex seeks immediate injunctive relief to enforce its ... - Feb 8, 2005 The decision upheld the US Food and Drug Administration's (FDA) classification of Periostat as an antibiotic drug which is not entitled to the patent and ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Small-Cap Firecrackers - Jul 7, 2006 CollaGenex markets three dermatological products and Periostat, a treatment for ... Periostat had been CollaGenex's revenue driver until May 2005, ... Smartmoney.com Alliance Pharma PLC - Interim Results. - Sep 13, 2006 Although sales of many of the products in the portfolio have continued to increase, we have been concentrating marketing investment this year on Periostat ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com … for doxycycline hyclate 20 mg tablets, the generic equivalent of... - Jun 6, 2005 According to IMS data, 2004 U.S. sales of Periostat tablets and doxycycline hyclate 20 mg tablets totaled $51 million. Ivax also received final FDA approval ... $9.94 - Drug Store News - Alacra Store CollaGenex Sees Rosacea Drug As Prescription for Turnaround - Aug 17, 2005 Mr. Benjamin said because Periostat, a similar drug, has been on the market ... In the meantime, with Periostat sales plummeting, CollaGenex expects to lose ... Subscription - Wall Street Journal Online - Dow Jones & Company Article: Make sure you always wear your best smile.(Lifestyle) - The... - Aug 31, 2006 The government ... in treating gum disease, said Dr. Sebastian ... bones that hold teeth in place. Periostat ... perhaps even halt, gum disease. ... Pay-Per-View - News Letter - HighBeam Research Company Profile Report - Apr 12, 2008 Atridox (Doxycycline Hyclate); Periostat (Doxycycline Hyclate); Periostat-MR (Doxycycline Hyclate Modified Release). Medical Devices. Dental. Treatment ... $50.00 - Revere Reports - Revere Article: Vioxx Trials May Focus on Stroke Victims - AP Online |... - Jul 29, 2007 ...are delighted to welcome Dr. Barnett to our board of directors ... launch of Periostat following FDA approval. ... "With Periostat, dentistry ... ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Competitors by Product Report - Apr 12, 2008 Products:. Atridox (Doxycycline Hyclate); Periostat (Doxycycline Hyclate); Periostat-MR (Doxycycline Hyclate Modified Release) ... $75.00 - Revere Reports - Revere 3 buys in pharma - March 20, 2006 - Mar 20, 2006 Meanwhile, Periostat lost patent protection, causing a drop in sales that put Collagenex in the red in 2004. Now the company markets a handful of ... CNNMoney.com CollaGenex Pharmaceuticals to Conduct Second Quarter 2005 Earnings … - Jul 19, 2005 CollaGenex currently sells Periostat(R) as the first and only pharmaceutical ... Periostat(R) is a registered trademark and Restoraderm(TM), IMPACS(TM) and ... RedOrbit CollaGenex Pharmaceuticals Reports Financial Results For the Third … - Nov 3, 2005 Following the launch of generic competition to Periostat in the second quarter of 2005, we discontinued virtually all dental sales and marketing activities, ... RedOrbit CollaGenex Pharmaceuticals to Present at the Roth Capital Partners... - Feb 14, 2005 Periostat is the first and only pharmaceutical to treat periodontal disease by ... Periostat is a registered trademarks of CollaGenex Pharmaceuticals, Inc. ... Free with registration - Business Wire - AccessMyLibrary.com York Pharma PLC acquires Derms Development Ltd from Merlin … - Oct 9, 2007 ...the development Periostat franchise in dentistry and…from generic ... the…day version of Periostat, the development of the Restoraderm technology, and… ... Pay-Per-View - deals - Alacra Store Collagenex responds to patent situation - Jul 21, 2006 Oracea contains doxycycline, the same active ingredient as CollaGenex's gum disease treatment Periostat. The company began focusing on its use in the ... Bizjournals.com Loislaw Federal District Court Opinions - COLLAGENEX … - Jun 15, 2005 Periostat® has always been known in the marketplace — The Court: But if it can ... What has been argued here is that the loss of profit from Periostat® will ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Legal Issues; Denial of motion to prevent launch of generic forms of ... - Apr 12, 2005 Periostat is the registered trademark of CollaGenex's proprietary 20 mg tablets of doxycycline hyclate approved by the FDA as a systemic adjunct to scaling ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Legal Issues; Denial of motion to prevent launch of generic forms of ... - Apr 15, 2005 Periostat is the registered trademark of CollaGenex's proprietary 20 mg tablets of doxycycline hyclate approved by the FDA as a systemic adjunct to scaling ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Legal Issues; Denial of motion to prevent launch of generic forms of ... - Apr 17, 2005 Periostat is the registered trademark of CollaGenex's proprietary 20 mg tablets of doxycycline hyclate approved by the FDA as a systemic adjunct to scaling ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones Subantimicrobial Dose Doxycycline -- Host Modulation in the Treatment... - Oct 1, 2005 It is low dose doxycycline hyclate 20mg (Periostat®) and is effective and safe ... Periostat® is an inhibitor of matrix metalloproteinases that have been ... Pay-Per-View - Oral Health Journal - Factiva, from Dow Jones Article: CollaGenex signs licensing agreement for dermatology... - Dec 20, 2006 Periostat MR for adult periodontitis, Oracea for the treatment of rosacea, and products ... for this technology, Periostat MR and Oracea, remain on track to ... Pay-Per-View - Philadelphia Inquirer - HighBeam Research Orally administered tablet - Sep 24, 2005 Periostat is an orally administered tablet to be taken twice daily, and can be an effective adjunctive treatment to scaling, root planing and deep cleaning ... Nature.com Business News in Brief - Nov 4, 2006 Oracea is a formulation of doxycycline, the same active ingredient in CollaGenex's gum-disease treatment Periostat. The company, a maker of specialty dental ... $2.95 - Philadelphia Inquirer - NewsBank WINNERS - Apr 24, 2005 ...of tetracyclines, which resulted in 27 patents and the development of Periostat, an oral remedy used in the treatment of adult periodontal diseases. ... Pay-Per-View - Newsday - ProQuest Archiver Treatments are prescribed for those with skin condition - Dec 30, 2005 First, Periostat, an antibiotic originally developed to treat gum disease, ... Dermatologists have found Periostat works extremely well for the inflammation ... Youngstown Vindicator Article: Be Aware of Manual 'Regens'. - Construction Equipment | … - Mar 1, 2008 Article: Periostat granted DPF status in U.K. Dental Products Report Europe; ... Prior to inclusion in the DPF, Periostat was available to periodontitis ... ... Pay-Per-View - Construction Equipment - HighBeam Research CollaGenex Pharmaceuticals to Present at the UBS Global Life Sciences... - Sep 19, 2006 CollaGenex also currently sells Periostat(R), which the Company developed as ... Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM), ... Free with registration - Business Wire - AccessMyLibrary.com CollaGenex Pharmaceuticals Announces Agreement to Acquire … - Dec 15, 2005 CollaGenex also sells Periostat(R), which it developed as the first pharmaceutical to ... Periostat(R) and Restoraderm(R) are registered trademarks and ... RedOrbit CollaGenex Pharmaceuticals to Present at the Lazard Capital Markets … - Nov 21, 2006 CollaGenex also currently sells Periostat(R), which the Company developed ... Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM) and ... Free with registration - Business Wire - AccessMyLibrary.com Q1 2006 CollaGenex Pharmaceuticals, Inc. Earnings Conference Call - … - May 3, 2006 Reflecting significantly reduced sales of Periostat following the introduction of generic competition in May of 2005. Turning to IMS prescription tracking ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com CollaGenex Pharmaceuticals to Sell $45.5 Million of Registered Common... - Nov 16, 2006 CollaGenex also currently sells Periostat(R), which the Company developed as ... Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM), ... Free with registration - Business Wire - AccessMyLibrary.com CollaGenex Pharmaceuticals' Announces Filing of Marketing … - Feb 27, 2006 CollaGenex also currently sells Periostat(R), which the Company developed ... Periostat(R) and Restoraderm(R) are registered trademarks and Oracea(TM) is a ... RedOrbit CollaGenex Pharmaceuticals Provides Update on Oracea Patent. - Jul 20, 2006 CollaGenex also currently sells Periostat(R), which the Company developed as ... Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM), ... Free with registration - Business Wire - AccessMyLibrary.com CollaGenex Pharmaceuticals to Present at the RBC Capital Markets … - Dec 6, 2006 CollaGenex also currently sells Periostat(R), which the Company developed as ... Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM), ... Free with registration - Business Wire - AccessMyLibrary.com CollaGenex Pharmaceuticals to Host First Quarter 2006 Earnings … - Apr 26, 2006 CollaGenex also currently sells Periostat, which the Company developed as the ... Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM), ... Free with registration - Business Wire - AccessMyLibrary.com CollaGenex Pharmaceuticals to Present at Jefferies Life Sciences … - Jun 21, 2006 CollaGenex also currently sells Periostat(R), which the Company developed as ... Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM), ... Free with registration - Business Wire - AccessMyLibrary.com CollaGenex Pharmaceuticals to Conduct Third Quarter 2005 Earnings … - Oct 20, 2005 Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM) and Oracea(TM) are trademarks of CollaGenex Pharmaceuticals, Inc. ... RedOrbit CollaGenex Pharmaceuticals to Host Second Quarter and First Half 2006... - Jul 24, 2006 CollaGenex also currently sells Periostat(R), which the Company developed ... Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM) and ... Free with registration - Business Wire - AccessMyLibrary.com CollaGenex Pharmaceuticals to Present at the Wachovia Securities 16th... - Jun 12, 2006 CollaGenex also currently sells Periostat(R), which the Company developed as ... Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM), ... Free with registration - Business Wire - AccessMyLibrary.com CollaGenex Pharmaceuticals Initiates Phase 2 Clinical Trial to... - Sep 26, 2005 Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM) and Oracea(TM) are trademarks of CollaGenex Pharmaceuticals, Inc. ... RedOrbit CollaGenex Pharmaceuticals to Present at the FBR 2006 Growth … - May 24, 2006 CollaGenex also currently sells Periostat, which the Company developed as the ... Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM), ... Genetic Engineering News - Genetic Engineering News (press release) CollaGenex Pharmaceuticals Appoints Douglas A. Poedtke As Vice … - Aug 29, 2005 Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM) and Oracea(TM) are trademarks of CollaGenex Pharmaceuticals, Inc. ... RedOrbit CollaGenex Pharmaceuticals Submits Response to USPTO Regarding … - Sep 1, 2006 CollaGenex also currently sells Periostat(R), which the Company developed as ... Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM), ... Free with registration - Business Wire - AccessMyLibrary.com FDA will consider CollaGenex skin drug - Oct 3, 2005 Last year, the company lost patent protection for its gum-disease treatment Periostat. Periostat has the same active ingredient, the antibiotic doxycycline, ... Philadelphia Business Journal Press Release: Merck, Pfizer Releases Data on Drugs to Treat Diabetes.... - Jun 25, 2007 Article: Determine the effect of administering Periostat [R] twice . ... Tablets [Periostat [R]] Administered Twice Daily for the Treatment of Acne Rosacea ... Pay-Per-View - M2 Presswire - HighBeam Research CollaGenex Pharmaceuticals to Present at the FTN Midwest Securities … - May 26, 2006 CollaGenex also currently sells Periostat, which the Company developed as the ... Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM), ... Free with registration - Business Wire - AccessMyLibrary.com CollaGenex Pharmaceuticals to Host Fourth Quarter 2005 Earnings … - Feb 22, 2006 CollaGenex also currently sells Periostat(R), which the Company developed ... Periostat(R) and Restoraderm(R) are registered trademarks and Oracea(TM) is a ... RedOrbit CollaGenex Pharmaceuticals to Present at the Lazard Capital Markets … - Nov 21, 2005 Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM) and Oracea(TM) are trademarks of CollaGenex Pharmaceuticals, Inc. ... RedOrbit CollaGenex Pharmaceuticals Appoints George Lasezkay to Its Board of … - Sep 22, 2005 Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM) and Oracea(TM) are trademarks of CollaGenex Pharmaceuticals, Inc. ... RedOrbit FDA first-time generics approvals--2005.(Special Report)(Illustration) - Feb 27, 2006 1 mg and 1 mg/0.09 mg MAY Doxycycline hyclate tablets USP, Periostat tablets 20 mg Doxycycline hyclate tablets USP, Periostat tablets 20 mg Doxycycline ... Free with registration - Chain Drug Review - AccessMyLibrary.com The sale of our industry - Jun 21, 2005 The company stopped marketing and selling Periostat. The decision was made after the FDA approved of a generic form of Periostat for sale by IVAX ... Woman Dentist Journal CollaGenex Pharmaceuticals to Present at the Fifth Annual Needham … - Jun 8, 2006 CollaGenex also currently sells Periostat(R), which the Company developed as ... Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM), ... Free with registration - Business Wire - AccessMyLibrary.com Oral therapy for rosacea. - Jan 1, 2006 Doxycycline hyclate 20 mg BID (Periostat) has recently been reported to be ... Periostat has been FDA approved since 1998 for the treatment of adult ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com Watch Your Mouth; Gums and Teeth Give Clues About What's Going On … - Aug 19, 2008 The Food and Drug Administration yesterday approved the drug Periostat for gum disease. The drug won't end the scraping ... is a whole new concept" in ... Pay-Per-View - Washington Post - HighBeam Research Article: Gum Disease, Pancreatic Cancer May Be Linked - The … - Jan 17, 2007 The Food and Drug Administration yesterday approved the drug Periostat for gum disease. The drug won't end the scraping ... is a whole new concept" in ... Pay-Per-View - Washington Post - HighBeam Research CollaGenex Pharmaceuticals Reports Notice of Allowance for European … - Mar 21, 2006 CollaGenex also currently sells Periostat, which the Company developed as the ... Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM), ... $4.95 - Business Wire - ECNext CollaGenex Pharmaceuticals to Present at the CE Unterberg, Towbin … - Oct 18, 2005 Periostat(R) and Restoraderm(R) are registered trademarks and IMPACS(TM) and Oracea(TM) are trademarks of CollaGenex Pharmaceuticals, Inc. ... $4.95 - Business Wire - ECNext OTHER NEWS TO NOTE.(Advanced Gene Expression Service Provider … - Mar 18, 2005 Periostat is sold as 20-mg tablets of doxycycline hyclate and is the only systemic adjunct to scaling and root planning for the treatment of adult ... Pay-Per-View - BIOWORLD Today - Factiva, from Dow Jones Brand Names/Synonyms: Periostat is also known by the following brand names and/or synonymsAlti-Doxycycline; Apo-Doxy; Atridox; DOXCYCLINE ANHYDROUS; Doryx; Doxy 100; Doxy-Caps; Doxy-Lemmon; Doxychel; Doxychel Hyclate; Doxycin; Doxycycline; Doxycycline Hyclate; Doxycycline Monohydrate; Doxylin; Doxytec; Doxytetracycline; GS-3065; Jenacyclin; Monodox; Novo-Doxylin; Nu-Doxycycline; Periostat; Supracyclin; Vibra-Tabs; Vibramycin Drug Category: Periostat is categorized under the following by the FDA: Antimalarials; Anti-bacterial Agents; Tetracyclines; ATC:A01AB22; ATC:J01AA02 Dosage Forms: Tablet; Capsule; Gel; Liquid; Powder; Powder for Solution Absorption: completely absorbed after oral administration Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 2-(amino-hydroxy-methylidene)-4-dimethylamino-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
